SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
106 hedge funds and large institutions have $475M invested in Syros Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
58% less call options, than puts
Call options by funds: $1.32M | Put options by funds: $3.17M
Holders
106
Holding in Top 10
2
Calls
$1.32M
Puts
$3.17M
Top Buyers
| 1 | +$17.8M | |
| 2 | +$6.73M | |
| 3 | +$6.3M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$5.87M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.14M |
Top Sellers
| 1 | -$9.95M | |
| 2 | -$4.14M | |
| 3 | -$1.83M | |
| 4 |
Millennium Management
New York
|
-$1.58M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.47M |